Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
76.00
+10.30 (15.68%)
Nov 2, 2026, 5:24 PM CET

STO:IBT.B Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,0246807221,212561750
Market Cap Growth
30.36%-5.78%-40.44%116.00%-25.15%-40.36%
Enterprise Value
915515496845193360
Last Close Price
65.7050.5053.6090.0050.0066.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--180517.0315745.8246775.77-
PB Ratio
16.696.464.243.971.691.90
P/TBV Ratio
16.696.464.243.971.691.90

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--123968.0310976.8916081.52-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-2.05-1.37-1.31-1.08-1.01-0.98
Net Debt / FCF Ratio
1.701.991.983.253.916.95
Quick Ratio
1.662.613.297.2718.8529.34
Current Ratio
1.672.723.337.4018.9330.03
Return on Equity (ROE)
-87.44%-47.29%-57.59%-38.65%-18.01%-10.77%
Return on Assets (ROA)
-33.89%-21.49%-30.75%-24.01%-10.85%-6.50%
Return on Capital Employed (ROCE)
-160.30%-65.50%-85.40%-44.10%-19.80%-11.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-8.00%-9.58%-18.96%-10.15%-11.66%-6.00%
FCF Yield
-7.24%-10.63%-15.67%-8.35%-15.29%-7.42%
Buyback Yield / Dilution
---8.95%-10.14%--